1 Min Read
Dec 19 (Reuters) - China Regenerative Medicine International Ltd
* HKLST and CRMI had decided to terminate negotiation of proposed transaction on 18 december 2016.
* Reference is made to announcement dated 17 august by hong kong life sciences and and china regenerative medicine
* Termination does not have any material adverse impact on financial position and business operation of hklst group and crmi group Source text for Eikon: Further company coverage: